Eemsdelta

Recro to Report Financial Results for Fourth Quarter And Year-End 2020 on February 26

Retrieved on: 
Friday, February 19, 2021

Recros management team will host a conference call and audio webcast at 4:30 p.m.

Key Points: 
  • Recros management team will host a conference call and audio webcast at 4:30 p.m.
  • ET on Friday, February 26, 2021 to discuss the financial results and recent operational highlights.
  • Recro (NASD: REPH ) is a revenue-generating contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing.
  • Contacts: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 [email protected] Tim Brons (Media) Vida Strategic Partners 415-675-7402 [email protected] Ryan D. Lake (CFO) Recro (484) 395-2436 [email protected]

Revolution Medicines to Participate in Digital RAS-Targeted Drug Discovery Summit and Upcoming Investor Conferences

Retrieved on: 
Thursday, February 18, 2021

Revolution Medicines also today announced that the company will participate in three upcoming investor conferences.

Key Points: 
  • Revolution Medicines also today announced that the company will participate in three upcoming investor conferences.
  • Additionally, replays of the webcasts will be available on the Events & Presentations page of the Revolution Medicines website for at least 14 days following the conference.
  • Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit high-value frontier targets in RAS-addicted cancers.
  • Contacts: For Investors: Vida Strategic Partners Stephanie Diaz 415-675-7401 [email protected] For Media: Vida Strategic Partners Tim Brons 415-675-7402 [email protected]